Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/8/1297/318786/mdi254.pdf
Reference42 articles.
1. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: Review and recommendations;Kaufman;J Clin Oncol,2003
2. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trial;Formenti;J Clin Oncol,2003
3. Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer Trial 10902;van der Hage;J Clin Oncol,2001
4. Treatment of locally advanced and inflammatory breast cancer;Hortobagyi,2000
5. Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel;von Minckwitz;J Clin Oncol,1999
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant Chemotherapy in Patients with HER2-Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran;Archives of Iranian Medicine;2024-04-01
2. Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods;Frontiers in Oncology;2022-10-24
3. Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism;Journal of Clinical Investigation;2022-07-01
4. Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study;The Breast;2021-04
5. A nomogram for predicting axillary pathologic complete response in hormone receptor–positive breast cancer with cytologically proven axillary lymph node metastases;Cancer;2020-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3